Osteogenesis Imperfecta: characterization of fractures during pregnancy and post-partum.
Breastfeeding
Fracture
Osteogenesis Imperfecta
Pregnancy
Journal
Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602
Informations de publication
Date de publication:
28 01 2022
28 01 2022
Historique:
received:
16
05
2021
accepted:
06
12
2021
entrez:
29
1
2022
pubmed:
30
1
2022
medline:
12
3
2022
Statut:
epublish
Résumé
Pregnancy and breastfeeding are associated with bone density loss. Fracture occurrence during pregnancy and post-partum, and its determinants, remain poorly known in Osteogenesis Imperfecta (OI). The aim of this study was to characterize fractures that occurred during pregnancy and post-partum in OI patients. We conducted a retrospective multicentric study including a total of 50 previously pregnant OI women from 10 Bone Centers in France. Among these patients, 12 (24%) patients experienced fractures during pregnancy or in the 6 months following delivery, and 38 (76%) did not experience any fracture. The most frequent localizations were: proximal femur (25%), spine (25%), distal femur (12.5%), and pelvis (12.5%). Fractures during pregnancy occurred during the third trimester and post-partum fractures occurred with a mean delay of 2 months following delivery. No fractures occurred during childbirth. We next compared the 12 patients with pregnancy or post-partum fractures with the 38 patients without fractures. Mean age at pregnancy was 32.7 ± 3.1 years-old in the fractured group, vs 29.3 ± 5.0 years-old in the non-fractured group (p = 0.002). Breastfeeding was reported in 85.7% of patients in the fractured group, vs 47.1% in the non-fractured group (p = 0.03). All patients with post-partum fractures were breastfeeding. Bone mineral density was significantly lower in patients with pregnancy-related fractures compared with other patients: spine Z-score - 2.9 ± 1.6DS vs - 1.5 ± 1.7DS (p = 0.03), and total hip Z-score - 2.0 ± 0.7DS vs - 0.5 ± 1.4DS (p = 0.04). At least one osteoporosis-inducing risk factor or disease other than OI was identified in 81.8% vs 58.6% of fractured vs non-fractured patients (not significant). Fracture during pregnancy or post-partum was not associated with the severity of OI. Bisphosphonates before pregnancy were reported in 16.7% and 21.1% of patients with pregnancy-related fractures and non-fractured patients, respectively (not significant). OI management during pregnancy and post-partum should aim for optimal control of modifiable osteoporosis risk factors, particularly in patients with low BMD. Breastfeeding should be avoided.
Sections du résumé
BACKGROUND
Pregnancy and breastfeeding are associated with bone density loss. Fracture occurrence during pregnancy and post-partum, and its determinants, remain poorly known in Osteogenesis Imperfecta (OI). The aim of this study was to characterize fractures that occurred during pregnancy and post-partum in OI patients.
RESULTS
We conducted a retrospective multicentric study including a total of 50 previously pregnant OI women from 10 Bone Centers in France. Among these patients, 12 (24%) patients experienced fractures during pregnancy or in the 6 months following delivery, and 38 (76%) did not experience any fracture. The most frequent localizations were: proximal femur (25%), spine (25%), distal femur (12.5%), and pelvis (12.5%). Fractures during pregnancy occurred during the third trimester and post-partum fractures occurred with a mean delay of 2 months following delivery. No fractures occurred during childbirth. We next compared the 12 patients with pregnancy or post-partum fractures with the 38 patients without fractures. Mean age at pregnancy was 32.7 ± 3.1 years-old in the fractured group, vs 29.3 ± 5.0 years-old in the non-fractured group (p = 0.002). Breastfeeding was reported in 85.7% of patients in the fractured group, vs 47.1% in the non-fractured group (p = 0.03). All patients with post-partum fractures were breastfeeding. Bone mineral density was significantly lower in patients with pregnancy-related fractures compared with other patients: spine Z-score - 2.9 ± 1.6DS vs - 1.5 ± 1.7DS (p = 0.03), and total hip Z-score - 2.0 ± 0.7DS vs - 0.5 ± 1.4DS (p = 0.04). At least one osteoporosis-inducing risk factor or disease other than OI was identified in 81.8% vs 58.6% of fractured vs non-fractured patients (not significant). Fracture during pregnancy or post-partum was not associated with the severity of OI. Bisphosphonates before pregnancy were reported in 16.7% and 21.1% of patients with pregnancy-related fractures and non-fractured patients, respectively (not significant).
CONCLUSIONS
OI management during pregnancy and post-partum should aim for optimal control of modifiable osteoporosis risk factors, particularly in patients with low BMD. Breastfeeding should be avoided.
Identifiants
pubmed: 35090500
doi: 10.1186/s13023-021-02148-x
pii: 10.1186/s13023-021-02148-x
pmc: PMC8796450
doi:
Substances chimiques
Bone Density Conservation Agents
0
Diphosphonates
0
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
22Informations de copyright
© 2022. The Author(s).
Références
Osteoporos Int. 2012 Apr;23(4):1213-23
pubmed: 21607805
J Med Genet. 1979 Apr;16(2):101-16
pubmed: 458828
Am J Med Genet A. 2019 Dec;179(12):2393-2419
pubmed: 31633310
Calcif Tissue Int. 2021 Feb 23;:
pubmed: 33620518
Bone. 2004 Mar;34(3):570-8
pubmed: 15003805
Curr Opin Pediatr. 2014 Aug;26(4):500-7
pubmed: 25007323
Osteoporos Int. 2017 Nov;28(11):3135-3142
pubmed: 28879474
Lancet. 2004 Apr 24;363(9418):1377-85
pubmed: 15110498
J Med Genet. 2013 Jan;50(1):21-4
pubmed: 23240094
J Pediatr. 1982 Nov;101(5):767-70
pubmed: 6982323
Curr Opin Endocrinol Diabetes Obes. 2014 Dec;21(6):468-75
pubmed: 25191853
Hum Mol Genet. 2009 Feb 1;18(3):463-71
pubmed: 18996919
Am J Clin Nutr. 1987 Aug;46(2):319-23
pubmed: 3618535
Physiol Rev. 2016 Apr;96(2):449-547
pubmed: 26887676
J Perinatol. 2016 Oct;36(10):828-31
pubmed: 27442154
Curr Osteoporos Rep. 2007 Sep;5(3):91-7
pubmed: 17925189
Endocr Rev. 1997 Dec;18(6):832-72
pubmed: 9408745
J Obstet Gynaecol. 2002 Mar;22(2):169-72
pubmed: 12521699
J Matern Fetal Neonatal Med. 2016;29(14):2358-62
pubmed: 26372357
J Bone Miner Res. 1996 Aug;11(8):1052-60
pubmed: 8854240
Lancet. 2016 Apr 16;387(10028):1657-71
pubmed: 26542481
J Bone Miner Res. 2016 Dec;31(12):2159-2166
pubmed: 27345018
Osteoporos Int. 2019 May;30(5):939-948
pubmed: 30671611